insurers

Insurers Take Aim at Big Pharma. This Small-Cap Stock Stands to Win
Insurers Take Aim at Big Pharma. This Small-Cap Stock Stands to Win
Motley Fool
insurers
generics
Catalent
Flag link:
Call for FDA to withdraw preterm birth drug divides doctors and insurers
Call for FDA to withdraw preterm birth drug divides doctors and insurers
Fierce Pharma
pre-term birth
Makena
physicians
insurers
FDA
Amag Pharmaceuticals
Flag link:
Trump And Pelosi Bring $15B Gift To Health Insurers
Trump And Pelosi Bring $15B Gift To Health Insurers
Forbes
insurers
Donald Trump
Nancy Pelosi
health insurance fee
legislation
Flag link:
Anthem Will Use Blockchain To Secure Medical Data For Its 40 Million Members In Three Years
Anthem Will Use Blockchain To Secure Medical Data For Its 40 Million Members In Three Years
Forbes
Anthem
insurers
blockchain
data
cybersecurity
Flag link:
Merck, insurers fight over $1.3B in damages from cyberattack: Bloomberg
Merck, insurers fight over $1.3B in damages from cyberattack: Bloomberg
Fierce Pharma
Merck
cybersecurity
cyberattack
insurers
Flag link:
The emergence of laboratory benefits managers: PBM déjà vu?
The emergence of laboratory benefits managers: PBM déjà vu?
Stat
diagnostics
laboratory benefits managers
LBMs
PBMs
insurers
Flag link:
U.S. Sponsors Of Health Insurance Lack Evidence-Based Transparency In Formulary Decisions
U.S. Sponsors Of Health Insurance Lack Evidence-Based Transparency In Formulary Decisions
Forbes
insurers
transparency
formulary
ICER
Flag link:
Why People With MS Need Permission from Insurers To Take Life-Saving Drugs. It’s Not The Reason You Think.
Why People With MS Need Permission from Insurers To Take Life-Saving Drugs. It’s Not The Reason You Think.
Forbes
MS
multiple sclerosis
patients
insurers
payers
drug pricing
Flag link:
Cigna rolls out plan to fully cover expensive gene therapies
Cigna rolls out plan to fully cover expensive gene therapies
Beckers Hospital Review
Cigna
insurers
gene therapy
Flag link:
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
Xconomy
PCSK9 inhibitors
Medicines Company
inclisiran
insurers
Flag link:
Amgen biosimilar debut boosted by UnitedHealthcare coverage switch
Amgen biosimilar debut boosted by UnitedHealthcare coverage switch
Biopharma Dive
insurers
Amgen
biosimilars
Avastin
Herceptin
Roche
UnitedHealthcare
Flag link:
Most insurers don't cover Eli Lilly's half-priced insulin
Most insurers don't cover Eli Lilly's half-priced insulin
Beckers Hospital Review
insulin
diabetes
drug pricing
Eli Lilly
PBMs
insurers
Flag link:
Humana takes aim at Mallinckrodt's 'ill-gotten' Acthar gains in lawsuit
Humana takes aim at Mallinckrodt's 'ill-gotten' Acthar gains in lawsuit
Endpoints
Humana
insurers
Mallinckrodt
H.P. Acthar Gel
Flag link:
Express Scripts Boosts Cigna As Employers Stick With Larger Insurer
Express Scripts Boosts Cigna As Employers Stick With Larger Insurer
Forbes
Cigna
insurers
Express Scripts
PBMs
Flag link:
Insurers Brace For Pfizer's $225K Heart Drug And Whether To Pay For It
Insurers Brace For Pfizer's $225K Heart Drug And Whether To Pay For It
Forbes
Pfizer
tafamidis
insurers
PBMs
ATTR
Flag link:
Rising Out-Of-Pocket Costs For Insulin Indicates Market Failure
Rising Out-Of-Pocket Costs For Insulin Indicates Market Failure
Forbes
diabetes
PBMs
insurers
insulin
drug pricing
Flag link:
U.S. Hospitals And Insurers Might Be Forced To Reveal The True Prices They Negotiate
U.S. Hospitals And Insurers Might Be Forced To Reveal The True Prices They Negotiate
NPR
insurers
hospitals
Donald Trump
list price
drug pricing
Flag link:
Here’s how Insys schemed to deceive insurance companies
Here’s how Insys schemed to deceive insurance companies
Boston Globe, MA
INSYS Therapeutics
racketeering
Fentanyl
insurers
Flag link:
Sanofi handed payers nearly $12B in drug rebates last year
Sanofi handed payers nearly $12B in drug rebates last year
Biopharma Dive
Sanofi
rebates
drug rebates
insurers
PBMs
Flag link:
Amid Medicare For All Talk, Insurance Industry Poll Says 66% Support 'Existing' System
Amid Medicare For All Talk, Insurance Industry Poll Says 66% Support 'Existing' System
Forbes
Medicare
insurers
healthcare reform
Flag link:

Pages